CLINICAL_TRIALS
research
· 2018-03-19
Clinical Trial Update: New Insights Into the Metabolic Syndrome: the Role of Alpha Defensin [NA]
Summary
This ClinicalTrials.gov entry reports ongoing research into the role of alpha defensin in metabolic syndrome, with the current status listed as UNKNOWN.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hillel Yaffe Medical Center | Conditions: Metabolic Syndrome | NA | Status: UNKNOWN